(Total Views: 326)
Posted On: 09/16/2020 3:40:53 PM
Post# of 154064
Agree about Tony and Pestell (though Tony was a C-suite guy at Gilead and Pestell an academic, not someone who has biotech and regulatory competence)...
A different perspective: who approved the Prostagene merger without doing due diligence about the prognostic test and whether it was ready? - Nader and BOD. That is on them... doing a merger without checking whether the main asset of the company you acquire has any value at all is a form of malfeasance in my book. Just like the convertible note settlement.
Much light, much shadow.
A different perspective: who approved the Prostagene merger without doing due diligence about the prognostic test and whether it was ready? - Nader and BOD. That is on them... doing a merger without checking whether the main asset of the company you acquire has any value at all is a form of malfeasance in my book. Just like the convertible note settlement.
Much light, much shadow.
(4)
(0)
